<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04988789</url>
  </required_header>
  <id_info>
    <org_study_id>2020/2320</org_study_id>
    <nct_id>NCT04988789</nct_id>
  </id_info>
  <brief_title>Evaluation of Paclitaxel Coated Balloon in the Treatment of Dialysis Access Dysfunction</brief_title>
  <official_title>Evaluation of Paclitaxel Coated Balloon in the Treatment of Dialysis Access Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Singapore General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Singapore General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recent studies of paclitaxel DCB in the treatment of stenosis at dialysis vascular access&#xD;
      have shown promising results. Paclitaxel, an anti-proliferation drug, is released during&#xD;
      balloon inflation and potentially improve primary patency by slowing down NIH effect.&#xD;
      However, meta-analysis have suggested that the use of paclitaxel in lower limbs have&#xD;
      increased risk of death in patients. The effect of paclitaxel DCB on dialysis access however&#xD;
      remains unknown. Hence, we aim to set up a database to track long-term treatment outcomes of&#xD;
      patients treated with Paclitaxel DCB at SGH for their stenosed dialysis access&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Circuit Access Patency</measure>
    <time_frame>12 Months</time_frame>
    <description>Circuit Access Patency is lost when AVF/AVG is intervened on</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary Assisted Patency</measure>
    <time_frame>12 months</time_frame>
    <description>Primary Assisted Patency is lost when circuit undergoes thrombectromy/thrombolysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Secondary Patency</measure>
    <time_frame>12 months</time_frame>
    <description>Secondary Patency is lost when entire dialysis access circuit is abandoned.</description>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Dialysis Access Malfunction</condition>
  <condition>Kidney Failure</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paclitaxel Drug Coated Balloon</intervention_name>
    <description>Failing AVF/AVGs treated with Paclitaxel Drug Coated balloons are captured in this database</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients above 21 that is undergoing AVF/AVG fistuloplasty with paclitaxel DCB at SGH&#xD;
        is included&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients above 21 that is undergoing AVF/AVG fistuloplasty with paclitaxel DCB at&#xD;
             SGH is included&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  All patients below 21&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Tang Tjun Yip</last_name>
    <role>Principal Investigator</role>
    <affiliation>Singapore General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Charyl Yap</last_name>
    <phone>6576 7986</phone>
    <email>Charyl.yap.j.q@sgh.com.sg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Singapore General Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>169856</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charyl Yap</last_name>
      <email>Charyl.yap.j.q@sgh.com.sg</email>
    </contact>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 25, 2021</study_first_submitted>
  <study_first_submitted_qc>July 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 4, 2021</study_first_posted>
  <last_update_submitted>July 25, 2021</last_update_submitted>
  <last_update_submitted_qc>July 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paclitaxel</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

